Mar­ket­ingRx roundup: Astel­las menopause drug led NFL TV spend­ing; A pod­cast's deep dive in­to Novo's his­to­ry

Astel­las in­tro­duces menopause drug to NFL au­di­ence: Astel­las spent more mon­ey ad­ver­tis­ing its menopause drug Veozah than any oth­er new brand on reg­u­lar NFL broad­casts in the 2023-2024 sea­son so far, ac­cord­ing to da­ta from re­al-time TV ad track­er iS­pot.tv. It spent $24.1 mil­lion from Sep­tem­ber through the first week of Jan­u­ary, with ES­PN, BET, AT&T, The Farmer’s Dog and Chili’s round­ing out the top new ad­ver­tis­ers this sea­son. Pfiz­er’s Nurtec and As­traZeneca’s Breztri Aeros­phere al­so made the top 10 new brands list at nos. 7 and 8, re­spec­tive­ly.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER